发明授权
- 专利标题: Presbyopia treatment by lens alteration of disulfide bonds and reduction
- 专利标题(中): 老花眼治疗通过镜片改变二硫键和还原
-
申请号: US13028766申请日: 2011-02-16
-
公开(公告)号: US08747829B2公开(公告)日: 2014-06-10
- 发明人: Jonathan S. Till , Ronald D. Blum
- 申请人: Jonathan S. Till , Ronald D. Blum
- 申请人地址: US VA Roanoke
- 专利权人: Encore Health, LLC
- 当前专利权人: Encore Health, LLC
- 当前专利权人地址: US VA Roanoke
- 代理机构: Sterne, Kessler, Goldstein & Fox PLLC
- 主分类号: A61K31/74
- IPC分类号: A61K31/74
摘要:
This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.
公开/授权文献
- US20110135622A1 Presbyopia Treatment by Lens Alteration 公开/授权日:2011-06-09
信息查询